Navigation Links
Bloomberg BNA Publishes Sixth Edition of False Claims Act Treatise
Date:3/1/2013

ARLINGTON, Va., March 1, 2013 /PRNewswire-USNewswire/ -- Bloomberg BNA has published the Sixth Edition of False Claims Act: Whistleblower Litigation, providing guidance and analysis of the False Claims Act (FCA) and the many different legislative developments and judicial opinions surrounding it, including qui tam cases in which a private citizen assists in a government prosecution and is paid a percentage of the recovery. Written by the trial lawyer called to testify before Congress on ways to modernize, update, and streamline the FCA, this treatise offers authoritative insights from one of the country's most experienced FCA lawyers.

(Logo: http://photos.prnewswire.com/prnh/20120110/DC33627LOGO)  

In False Claims Act: Whistleblower Litigation, Sixth Edition, practitioners will find discussion of:

  • Pharmaceutical company liability
  • Circuit-by-circuit analysis of Civil Rule 9(b) to FCA complaints
  • Bankruptcy proceedings
  • Statute of limitations for whistleblower employment protections
  • Identifying alternate proceedings
  • Disclosure of defendants' fee information
  • Settlement challenges by realtors, non-settling defendants, and the government
  • State and municipal FCA statutes

Since publication of the Fifth Edition in 2007 by Top Gun Publishing LLC (Cincinnati, Ohio), Congress has amended the FCA three times and the courts have issued more than 2,000 opinions related to the Act. These amendments are fully examined and explained in the Sixth Edition, as are the sometimes conflicting court opinions that have resulted in procedural minefields and other obstacles to proving liability. The Sixth Edition also includes a chapter that details all U.S. Supreme Court opinions related to the Act; a chapter on the numerous state FCAs that have been enacted; and a comprehensive, searchable collection of appendices that provide more than 40 letters, complaints, statements, interrogatories, requests, motions, and affidavits.

With the Sixth Edition, practitioners have all the model forms and procedures needed to effectively litigate qui tam cases. The treatise also includes a table of cases and all versions of this statute and its legislative history, providing a quick reference for both plaintiff and defense attorneys. The Sixth Edition also provides samples of motions in limine used in recent cases; HIPAA and PHSA complaint protective orders; United States Bankruptcy Court Proof of Claim and Application of Trustee to Employ Special Counsel; attorneys' fees and costs application, declaration of counsel, and affidavit in support of an expert; and jury instructions, special interrogatories, and verdict form.

False Claims Act: Whistleblower Litigation, Sixth Edition is authored by James B. Helmer, Jr. , a Senior Partner and President of Helmer, Martins, Rice & Popham Co., L.P.A., in Cincinnati, Ohio. The previous edition was published by Top Gun Publishing LLC (Cincinnati, Ohio). This treatise is available for sale directly from Bloomberg BNA and also will be available on the Bloomberg Law legal research system.

Bloomberg BNA, a wholly owned subsidiary of Bloomberg, is a leading source of legal, regulatory, and business information for professionals. In addition to False Claims Act: Whistleblower Litigation, Bloomberg BNA publishes: Director and Officer Liability in Financial Institutions: A Deskbook; Criminal Tax, Money Laundering, and Bank Secrecy Act Litigation; Whistleblowing: The Law of Retaliatory Discharge; and other titles in litigation. Visit us online for a free catalog, call 1.800.960.1220, or send an email request to books@bna.com.

False Claims Act: Whistleblower Litigation may be purchased (1,594 pp. Hardcover, Order #2197-PR12/$395.00 plus tax, shipping, and handling) from Bloomberg BNA, Book Division, PO Box 7814, Edison, NJ 08818-7814. Telephone orders: 1.800.960.1220. Fax orders: 1.732.346.1624. A 10% discount is available on print copies of books when ordering from the website at www.bna.com/bnabooks. Please note that discounts cannot be combined.

Editors: Review copy available upon request.
Please email Anna Bailey at abailey@bna.com, or call 703.341.5767
Follow us on Twitter @BloombergBNA and @annaebailey6


'/>"/>
SOURCE Bloomberg BNA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New York City Mayor Bloomberg and Health Commissioner Farley Receive Flu Shot at Duane Reade Pharmacy, Highlight Importance of Flu Preparedness
2. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
3. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
4. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
5. Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
6. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
7. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
8. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
9. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
10. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
11. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 2017 7D Surgical announced today that ... U.S. Food and Drug Administration (FDA) and a ... North American commercial launch of its innovative Machine-vision ... the 7D Surgical System.  The ... and machine vision algorithms to eliminate the long-standing ...
(Date:1/23/2017)... DUBLIN , Jan 23, 2017 Research and ... Market Analysis & Trends - Product - Forecast to 2025" report ... Report Highlights: ... current and future market trends to identify the investment opportunities ... numbers Key market trends across the business segments, Regions ...
(Date:1/23/2017)... January 23, 2017 Varias ... enal) y el riesgo de ... a pabetalone    Resverlogix Corp. ("Resverlogix" ... preliminares de un ensayo en fase 1 con sede ... riñón (renal) severa. Los datos demostraron unos resultados importantes ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate ... about the benefits of making new water infrastructure a number one priority. “As we ... we expect water infrastructure to become a top priority of our new political change ...
(Date:1/23/2017)... ... 2017 , ... Moisture measurement is a necessary process step ... to success. Selecting an inappropriate measurement method can cause costly errors, and poor ... equipment. Rare or expensive substances are wasted and production may even be stopped ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), the Foundation ... the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... programs and resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching communities ... These resources have been developed for use by nutrition educators and influencers ...
(Date:1/22/2017)... ... January 22, 2017 , ... Phytocéane invites clients to ... the rest of the world with ZANZIBAR MILKY CREAM. Inspired by the beauty of ... like Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, velvety body ...
Breaking Medicine News(10 mins):